R. Ramharack et al., Recombinant adenovirus vector mediated expression of lipoprotein (a) [Lp(a)] in rabbit plasma, BBA-MOL C B, 1438(3), 1999, pp. 322-328
Citations number
33
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
Lipoprotein (a) [Lp(a)] is a heterodimer of apolipoprotein (a) [apo(a)] and
apolipoprotein B-100 (apoB-100) of low density lipoprotein linked by a dis
ulfide bond. Apo(a) and apoB-100 are synthesized by the liver and covalentl
y associate or couple to form Lp(a) extracellularly. Elevated plasma Lp(a)
is an independent risk factor for vascular injury disorders such as resteno
sis after balloon angioplasty and accelerated graft atherosclerosis followi
ng heart transplantation. Lp(a) is not expressed in laboratory animals maki
ng studies of its pathophysiology difficult. To overcome this problem, we e
xplored the possibility of generating Lp(a) in rabbit plasma using replicat
ion-deficient adenovirus vector mediated gene delivery. Rabbits were chosen
because of their large vessels and unlike mouse or rat, rabbit apoB-100 co
uld interact with apo(a) to generate Lp(a). The recombinant (r) adenovirus
vector construct used encoded a 200 kDa apo(a) [Ad-apo(a)]. Ad-apo(a) injec
tion into the rabbit marginal vein caused the appearance of plasma rLp(a).
Injection of a r adenovirus vector expressing the bacterial LacZ gene (Ad-L
acZ) or PBS (vehicle) did not result in detectable plasma rLp(a). These are
the first results to demonstrate plasma expression of rLp(a) in rabbits us
ing adenovirus vector mediated gene transfer. Therefore, this system may be
suitable for investigating Lp(a)'s role in the development of vascular inj
ury diseases in a rabbit model. (C) 1999 Elsevier Science B.V. All rights r
eserved.